![](/wp-content/uploads/2016/07/TRIANGLE-948.jpg)
(vil az’ ah dohn)
Viibryd
PREGNANCY CATEGORY C
Drug Classes
Antidepressant
SSRI
Therapeutic Actions
Acts as an antagonist at central serotonin receptor sites and as an SSRI; this action is thought to account for its antidepressive effect.
Indications
Treatment of adults with major depressive disorder
Available Forms
Tablets—10, 20, 40 mg
Dosages
Adults
Initially, 10 mg/day PO for 7 days, followed by 20 mg/day PO for 7 days; then increase to maintenance dosage of 40 mg/day PO taken with food.
Pediatric patients
Safety and efficacy not established.
Pharmacokinetics
|
Metabolism: Hepatic: T1/2; 25 hr
![](https://freepngimg.com/download/social_media/63059-media-icons-telegram-twitter-blog-computer-social.png)
Stay updated, free articles. Join our Telegram channel
![](https://clinicalpub.com/wp-content/uploads/2023/09/256.png)
Full access? Get Clinical Tree
![](https://videdental.com/wp-content/uploads/2023/09/appstore.png)
![](https://videdental.com/wp-content/uploads/2023/09/google-play.png)